. We demonstrated that muscle-derived stem/progenitor cells (MDSPCs) isolated from the skeletal muscle of naturally aged wild-type (WT) mice and mice that model a human progeroid syndrome (ERCCI-deficient mice) are defective in proliferation, multi-lineage differentiation and tissue regeneration after injury. This is consistent with the notion that autonomous defects in the adult stem cell compartment, which accrue over time, contribute to the loss of tissue regeneration and homeostasis associated with normal and accelerated aging. However, there is also evidence that aging and disease affects the stem cell niche, impacting stem cell function via non-autonomous mechanisms. In addition, there is strong evidence that factors circulating in the serum of aged mice affect stem/progenitor cell function. Therefore, it remains unclear if aging-related loss of adult stem cell function is primarily driven by cell autonomous and/or non-autonomous mechanisms. Thus one goal of this project is to characterize the mechanism through which MDSPCs become dysfunctional with aging using mouse models of tissue- and cell type-specific inactivation of ERCCI. The proposed experiments will determine if stochastic, endogenous damage directly or indirectly drives stem cell dysfunction. We also demonstrated that intraperitoneal administration of MDSPCs isolated from young WT mice into ERCCI-deficient mice results in a significant lifespan and healthspan extension, as well as increased tissue regeneration and neovascularization. This occurred via a paracrine/endocrine mechanism as donor cells were not detected in all tissues in which benefits were seen. Thus a second goal of this project is to characterize this paracrine/endocrine mechanism by which young MDSPCs promote health and longevity when delivered systemically. Finally we will identify the factors secreted by young, functional stem cells that are important for conferring their beneficial effects. The successful completion ofthe proposed studies should lead to novel mechanistic information about the contribution of stem cells to maintaining healthspan and therapeutic stem cell-based approaches to improve human aging.

Public Health Relevance

;The proposed experiments will serve to determine if defects accumulate in adult stem cells during the aging through cell autonomous and non-autonomous mechanisms and identify factors secreted by young, functional stem cells that could be used therapeutically to improve human health.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-2)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Niedernhofer, L J; Kirkland, J L; Ladiges, W (2016) Molecular pathology endpoints useful for aging studies. Ageing Res Rev :
Robbins, Paul D; Dorronsoro, Akaitz; Booker, Cori N (2016) Regulation of chronic inflammatory and immune processes by extracellular vesicles. J Clin Invest 126:1173-80
Zhang, Changqing; Ferrari, Ricardo; Beezhold, Kevin et al. (2016) Arsenic Promotes NF-Κb-Mediated Fibroblast Dysfunction and Matrix Remodeling to Impair Muscle Stem Cell Function. Stem Cells 34:732-42
Ivanisevic, Julijana; Stauch, Kelly L; Petrascheck, Michael et al. (2016) Metabolic drift in the aging brain. Aging (Albany NY) 8:1000-20
Zhu, Yi; Tchkonia, Tamara; Fuhrmann-Stroissnigg, Heike et al. (2016) Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15:428-35
Flores, Rafael R; Kim, Eun; Zhou, Liqiao et al. (2015) IL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD mice. Eur J Immunol 45:3114-25
Wallace, Callen T; St Croix, Claudette M; Watkins, Simon C (2015) Data management and archiving in a large microscopy-and-imaging, multi-user facility: Problems and solutions. Mol Reprod Dev 82:630-4
Kelley, Eric E (2015) Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase. Arch Toxicol 89:1193-207
Reay, Daniel P; Bastacky, Sheldon I; Wack, Kathryn E et al. (2015) D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity. Mol Med 21:442-52
Mu, Xiaodong; Tang, Ying; Lu, Aiping et al. (2015) The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy. Hum Mol Genet 24:2923-37

Showing the most recent 10 out of 33 publications